Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
20/04/2026 12:58
April 20 (Reuters) - NewcelX AG NCEL.O: NEWCELX UPDATES CORPORATE PRESENTATION TO HIGHLIGHT TYPE 1 DIABETES FLAGSHIP PROGRAM FOLLOWING STRATEGIC COLLABORATION WITH ELEDON PHARMACEUTICALS AHEAD OF SWISS BIOTECH CONFERENCE Source text: ID:nGNX7YcXmJ Further company coverage: NCEL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing